StockData
Provectus Biopharmaceuticals, Inc. logo

Provectus Biopharmaceuticals, Inc. (PVCT) stock

PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$0.05+0.00 (+0.39%)

Close on Oct 19, 2026Market cap $20.55MP/E –Yield –

Provectus Biopharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Provectus Biopharmaceuticals's total debt was $23.62K at Dec 31, 2025. For fiscal 2025 it was $23.62K.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$23.62K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$23.62K–
Q3 FY2025Sep 30, 2025$23.62K–
Q3 FY2020Sep 30, 2020$39.06K–
Q2 FY2020Jun 30, 2020$39.06K–

More Provectus Biopharmaceuticals figures

See a number that looks wrong?